Belite Bio Inc Statistics Share Statistics Belite Bio Inc has 32.6M
shares outstanding. The number of shares has increased by 6.31%
in one year.
Shares Outstanding 32.6M Shares Change (YoY) 6.31% Shares Change (QoQ) 2.26% Owned by Institutions (%) 0.48% Shares Floating 15.17M Failed to Deliver (FTD) Shares 1,510 FTD / Avg. Volume 2.85%
Short Selling Information The latest short interest is 169.43K, so 0.52% of the outstanding
shares have been sold short.
Short Interest 169.43K Short % of Shares Out 0.52% Short % of Float 1.15% Short Ratio (days to cover) 4.46
Valuation Ratios The PE ratio is -53.31 and the forward
PE ratio is -34.99.
Belite Bio Inc's PEG ratio is
63.44.
PE Ratio -53.31 Forward PE -34.99 PS Ratio 0 Forward PS 124 PB Ratio 13.21 P/FCF Ratio -65.58 PEG Ratio 63.44
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Belite Bio Inc.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 24.31,
with a Debt / Equity ratio of 0.
Current Ratio 24.31 Quick Ratio 24.31 Debt / Equity 0 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage -1999.8
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.45M Employee Count 25 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 6K Effective Tax Rate -0.02%
Stock Price Statistics The stock price has increased by 28.88% in the
last 52 weeks. The beta is -1.5, so Belite Bio Inc's
price volatility has been lower than the market average.
Beta -1.5 52-Week Price Change 28.88% 50-Day Moving Average 62.94 200-Day Moving Average 63.29 Relative Strength Index (RSI) 45.36 Average Volume (20 Days) 52,920
Income Statement
Revenue n/a Gross Profit -449K Operating Income -40M Net Income -36.14M EBITDA -35.67M EBIT -36.12M Earnings Per Share (EPS) -1.18
Full Income Statement Balance Sheet The company has 31.68M in cash and 537K in
debt, giving a net cash position of 31.14M.
Cash & Cash Equivalents 31.68M Total Debt 537K Net Cash 31.14M Retained Earnings -107.65M Total Assets 164.2M Working Capital 153.16M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -29.23M
and capital expenditures -151K, giving a free cash flow of -29.39M.
Operating Cash Flow -29.23M Capital Expenditures -151K Free Cash Flow -29.39M FCF Per Share -0.96
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
